Vivus (VVUS) shares resume trading, +90.6% after an FDA advisory panel votes to recommend Qnexa....

|By:, SA News Editor

Vivus (VVUS) shares resume trading, +90.6% after an FDA advisory panel votes to recommend Qnexa. Also with weight-loss drugs waiting for approvalARNA +18.8%, OREX +14%.